N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.
N.A. Lopatkin Institute of Urology, Moscow, Russia.
Anal Cell Pathol (Amst). 2020 Aug 20;2020:5424780. doi: 10.1155/2020/5424780. eCollection 2020.
Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) contribute significantly to the development of immunosuppressive properties of a tumor. In this study, we performed immunohistochemical analysis of immune cells of esophageal tumors stroma.
Paraffin-embedded tissue specimens from 48 esophageal squamous cell carcinoma (ESCC) patients were retrospectively collected for immunohistochemical analysis of stromal cells. For staining of macrophages, CD68, CD163, CD206, PU.1, and iNOS were used. For T cell detection, CD8, CD3, and FOXP3 were used. Also, we performed staining for PD-L1 that can be expressed on TAMs and tumor cells. Clinicopathological and survival data were collected and analyzed using the and Fisher exact tests, Kaplan-Meier curves, and the log-rank test. The correlation analysis was performed with Spearman's rank correlation coefficient.
We found that FOXP3 expression was associated with age ( = 0.042) and iNOS expression was associated with the disease stage ( = 0.044). In addition, FOXP3 and CD163 appeared to be markers of good prognosis (HR = 0.4420, = 0.0325, and HR = 0.4447, = 0.0456, respectively). Significant association between PU.1+ and CD68+ macrophages ( = 0.833; ≤ 0.001) and between PU.1+ and CD163+ macrophages ( = 0.500; ≤ 0.001) was established; positive association between PU.1 and CD206 expression was also observed ( = 0.250; = 0.043).
Large amounts of CD163+ macrophages and FOXP3+ Т cells appear to be markers of good prognosis of ESCC. The number of PU.1+ macrophages strongly correlates with the number of CD68+ macrophages; therefore, usage of PU.1 as a potential macrophage marker can be recommended for esophageal tumors.
肿瘤相关巨噬细胞(TAMs)和肿瘤浸润淋巴细胞(TILs)对肿瘤免疫抑制特性的发展有重要贡献。在这项研究中,我们对食管肿瘤基质中的免疫细胞进行了免疫组织化学分析。
回顾性收集 48 例食管鳞状细胞癌(ESCC)患者的石蜡包埋组织标本,进行基质细胞的免疫组织化学分析。用于巨噬细胞染色的标志物包括 CD68、CD163、CD206、PU.1 和 iNOS。用于 T 细胞检测的标志物包括 CD8、CD3 和 FOXP3。此外,我们还对 TAMs 和肿瘤细胞上可表达的 PD-L1 进行了染色。使用 和 Fisher 确切检验、Kaplan-Meier 曲线和对数秩检验收集和分析临床病理和生存数据。使用 Spearman 秩相关系数进行相关性分析。
我们发现 FOXP3 表达与年龄相关( = 0.042),iNOS 表达与疾病分期相关( = 0.044)。此外,FOXP3 和 CD163 似乎是预后良好的标志物(HR = 0.4420, = 0.0325,HR = 0.4447, = 0.0456)。我们还建立了 PU.1+和 CD68+巨噬细胞( = 0.833; ≤ 0.001)以及 PU.1+和 CD163+巨噬细胞( = 0.500; ≤ 0.001)之间的显著相关性;同时还观察到 PU.1 与 CD206 表达之间的正相关( = 0.250; = 0.043)。
大量的 CD163+巨噬细胞和 FOXP3+T 细胞似乎是 ESCC 预后良好的标志物。PU.1+巨噬细胞的数量与 CD68+巨噬细胞的数量强烈相关;因此,建议将 PU.1 作为潜在的巨噬细胞标志物用于食管肿瘤。